Next-Gen MPN Care: Highlighting Research from Memorial Sloan Kettering with Dr. Raajit Rampal
Join the HealthTree Foundation for an exclusive look into the cutting-edge MPN research happening at Memorial Sloan Kettering with renowned expert Dr. Raajit Rampal. This session will explore the latest advancements in targeted therapies and genomic discoveries that are shaping the future of personalized care for myeloproliferative neoplasms. Gain valuable insights into how these next-generation treatments are moving from the lab to the clinic to improve outcomes and quality of life for the MPN community.
Dalton introduces the agenda of the event and featured speaker Raajit Rampal, MD
Join the HealthTree Foundation for an exclusive look into the cutting-edge MPN research happening at Memorial Sloan Kettering with renowned expert Raajit Rampal.
Bring your questions!
Dalton Bean
Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Raajit Ramal, MD, PhD
Raajit Rampal, MD, PhD, is a Hematological Oncologist at the Memorial Sloan Kettering Cancer Canter, New York, KY, specializing in myeloproliferative neoplasms (MPNs) and leukemia. Dr. Rampal is a dedicated and active researcher focusing on developing new and innovative approaches to treating MPNs and leukemia. He also works to develop and run novel clinical trials with molecularly targeted agents for patients with MPNS and leukemia.